Masimo announced today that in a randomized controlled study involving 150 ICU patients recently published as a letter in Intensive Care Medicine, researchers investigated whether monitoring with Masimo ORi™ could reduce the time critically ill patients spend with moderate hyperoxia, compared to monitoring with oxygen saturation alone.1 ORi is an index of oxygenation in the moderate hyperoxic region, …

source https://finance.yahoo.com/news/study-investigates-utility-masimo-ori-060000930.html?.tsrc=rss